- Filed
- Nov 10, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 7, 2025 | 436.55M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 448.16M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 331.97M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 249.95M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 227.9M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $273K |
| Capex | Q3 2025 · Sep 30, 2024 | $304K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$20.12M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | −$23.31M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $104.85M |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $135.4M |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $0 |
| Short Term Debt | Q3 2025 · Dec 31, 2024 | $818K |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $456.58M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $50.14M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $610.02M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $266.55M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | −$3.71M |
| Stockholders Equity restated | Q3 2025 · Sep 30, 2024 | $127.46M |
| Stockholders Equity restated | Q3 2025 · Jun 30, 2024 | $134.75M |
| Stockholders Equity restated | Q3 2025 · Dec 31, 2023 | −$30M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $197.92M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $202.97M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $309.74M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $347.49M |
| Current Assets | Q3 2025 · Sep 30, 2025 | $619.76M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $93.76M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $919.76M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $343.78M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.03 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.87 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$0.06 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$0.69 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $0.01 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.87 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$0.06 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$0.69 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $25.26M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $69.47M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $17.49M |
| Sga Expense | Q3 2025 · Sep 30, 2024 | $57.8M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $3.38M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $11.93M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $3.82M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $8.53M |
| Net Income | Q3 2025 · Sep 30, 2025 | $2.52M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$288.08M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$15.14M |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$157.37M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$21.86M |
| Operating Income | Q3 2025 · Sep 30, 2025 | −$133.37M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$10.54M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$125.28M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $7.43M |
| Gross Profit | Q3 2025 · Sep 30, 2025 | $22.93M |
| Gross Profit | Q3 2025 · Sep 30, 2024 | $10.77M |
| Gross Profit | Q3 2025 · Sep 30, 2024 | $28.82M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $25.71M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $77.44M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $30.74M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2024 | $85.59M |
| Revenue | Q3 2025 · Sep 30, 2025 | $33.14M |
| Revenue | Q3 2025 · Sep 30, 2025 | $100.37M |
| Revenue | Q3 2025 · Sep 30, 2024 | $41.51M |
| Revenue | Q3 2025 · Sep 30, 2024 | $114.41M |